Aaron Young

Aaron Young has a diverse and extensive work experience in the pharmaceutical and biotechnology industry. Aaron most recently served as the Chief Intellectual Property Officer at Kiniksa Pharmaceuticals, where they played a key role in the development and delivery of therapeutics for patients with unmet medical needs. Prior to that, Aaron held positions at Synageva BioPharma Corp., Genzyme, and Wyeth Pharmaceuticals, focusing on intellectual property and patent counsel. Aaron also gained legal experience as an Associate at Testa, Hurwitz & Thibeault, LLP, and as a Legal Intern at DEKA Research & Development. Overall, Aaron has demonstrated their expertise in the field and their ability to contribute to the growth and success of companies in the industry.

Aaron Young's education history begins in 1989 when they attended the University of Southern California, where they obtained a Bachelor of Arts (B.A.) degree in Biological Sciences in 1993. Aaron then went on to pursue further education, attending UMass Chan Medical School from 1994 to 1999, where they earned a Doctor of Philosophy (PhD) degree in Cellular and Molecular Biology. Finally, Aaron Young attended the UNH Franklin Pierce School of Law from 1999 to 2002, where they achieved a Doctor of Law (JD) degree with a specialization in Intellectual Property Law.